Forum

@jennifer-carroll Hi! In response to the latest Guidance on distinction between
advertising and other activities for health products update (Aug 2023). They have now mentioned that 'Declaration of sponsorship of such materials, by name or logo, is required and does not in itself render the material promotional.' under Medical condition and treatment awareness materials.

Has the PAAB code been updated to reflect this change? Do we now have to include manufacturer name on unbranded disease awareness pieces?

Can a main creative image of an ad be based on a PRO (related to functionality) that is only listed in the TMA as a component of a primary endpoint (data included in the TMA but statistical analysis only included in the primary publication).

Hi! Can you please clarify the need for listing formulary references on APS (layout) for formulary coverage claims? We were under the impression that a qualifying footnote of corresponding provincial areas or territories was enough; and including the list of formulary references as FPO in the copydecks was sufficient. We have seen this previously accepted in other ads, as it would get redundant and long to list every reference.

Hi @jennifer-carroll !

Regarding point #1 above, we've had some contradicting guidance in the last few weeks about approving straight renewals with the old PAAB logo to use printed quantities remaining. Based on the above, the approval period will continue for 12-months with the understanding that if a reprint is required, the logo needs to be updated.

We have also received this in terms of guidance: Please note that we are continuing to issue approvals for renewals which are required to deplete old stock for pieces that do not require any additional updates; however distribution of the old stock must cease by September 30, 2021 and if the APS is reprinted within the acceptance period, it should be reprinted with the new PAAB logo.

Can you confirm which is accurate or where I can find more information about this?

If a branded piece is created, (with no product claims, only the product logo) and contains space to include a sales representative business card and invite to connect virtually, would this be considered a person-to-person communication and not subject to PAAB review?

@Jennifer-Carroll Hi!
Can you clarify if the same guidance (if the entire PAAB approved print document is converted with no change in copy, flow or layout, it would not require an additional PAAB preclearance/review) is applicable for conference material? Many conferences have now gone virtual and allow for a virtual booths and/or pull-up banners.

Hi @Jennifer-Carroll,
Can you clarify if there is any guidance on proximity between branded and unbranded communications? As we understand that branded and unbranded tools require separate emails.